TECH vs VICR · P/E 65, rev $1.22B vs P/E 87, rev $359.1M
Bio-Techne Corp (TECH) versus Vicor Corporation (VICR) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Vicor Corporation (VICR) is a electronic components company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VICR revenue for 2024-12-31 was $359.1M. Net income was $6.1M. Revenue was down 11.4% from 2023-12-31 to 2024-12-31. VICR currently screens at market cap $2.09B and trailing P/E 87.3.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VICR currently screens at market cap $2.09B and trailing P/E 87.3.
Not investment advice. Open the TECH and VICR stock pages for the full models.
Not investment advice.